Literature DB >> 7260988

Disposition of cefoxitin in patients with pleural effusion.

M Barrueco, M J Garcia, M J Otero, A Dominguez-Gil, J M de Letona.   

Abstract

The pharmacokinetics of cefoxitin were studied in nine patients with pleural effusion of varied etiologies. All patients received a single intravenous bolus of 30 mg/kg. Cefoxitin levels were determined simultaneously in plasma and pleural fluid by means of a microbiologic plate diffusion method. The antibiotic follows a two-compartment open kinetic model. In the pleural fluid, maximum concentrations of cefoxitin of 19.72 +/- 9.72 microgram/ml were reached two hours after administration. The fraction of the antibiotic that reaches the pleural fluid represents 0.22% to 4.03% of the dose administered. The disappearance constant of the antibiotic from the pleural fluid is significantly smaller (Kd = 0.15 +/- 0.03 hours-1) than the elimination constant determined from the plasma levels (K13 = 2.27 +/- 0.90 hours-1). Cefoxitin was always found in antibacterial concentration in the pleural fluid for a considerable period of time.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7260988

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  4 in total

Review 1.  Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.

Authors:  Federico Pea; Pierluigi Viale; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

2.  The influence of uremia on the accessibility of phosphomycin into interstitial tissue fluid.

Authors:  C Fernandez Lastra; E L Mariño; A Dominguez-Gil; J M Tabernero; A Gonzalez Lopez; M Yuste Chaves
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  Disposition of phosphomycin in patients with pleural effusion.

Authors:  C F Lastra; E L Mariño; M Barrueco; M S Gervós; A D Gil
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

4.  Disposition of cefoxitin in patients with ascites.

Authors:  M J Garcia; A Dominguez-Gil; F D Perez; F P Rodriguez; F D Moronta
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.